These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 29882046)

  • 21. Development of C-TILDA: A modified TILDA method for reservoir quantification in long term treated patients infected with subtype C HIV-1.
    Bertoldi A; D'Urbano V; Bon I; Verbon A; Rokx C; Boucher C; van Kampen JJA; Gruters RA; Gallinella G; Calza L; Mahmoudi T; De Crignis E; Re MC
    J Virol Methods; 2020 Feb; 276():113778. PubMed ID: 31756409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy.
    Araínga M; Edagwa B; Mosley RL; Poluektova LY; Gorantla S; Gendelman HE
    Retrovirology; 2017 Mar; 14(1):17. PubMed ID: 28279181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged administration of maraviroc reactivates latent HIV in vivo but it does not prevent antiretroviral-free viral rebound.
    López-Huertas MR; Gutiérrez C; Madrid-Elena N; Hernández-Novoa B; Olalla-Sierra J; Plana M; Delgado R; Rubio R; Muñoz-Fernández MÁ; Moreno S
    Sci Rep; 2020 Dec; 10(1):22286. PubMed ID: 33339855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication competence of virions induced from CD4+ lymphocytes latently infected with HIV.
    Richman DD; Huang K; Lada SM; Sun X; Jain S; Massanella M; Menke B
    Retrovirology; 2019 Feb; 16(1):4. PubMed ID: 30770748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 Tat commandeers nuclear export of Rev-viral RNA complex by controlling hnRNPA2-mediated splicing.
    Yandrapally S; Sarkar S; Banerjee S
    J Virol; 2023 Nov; 97(11):e0104423. PubMed ID: 37905837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in inducibility of the latent HIV reservoir in perinatal and adult infection.
    Dhummakupt A; Rubens JH; Anderson T; Powell L; Nonyane BA; Siems LV; Collinson-Streng A; Nilles T; Jones RB; Tepper V; Agwu A; Persaud D
    JCI Insight; 2020 Feb; 5(4):. PubMed ID: 31999647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV Persistence, Latency, and Cure Approaches: Where Are We Now?
    Chou TC; Maggirwar NS; Marsden MD
    Viruses; 2024 Jul; 16(7):. PubMed ID: 39066325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
    Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
    Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components.
    Likhoshvai VA; Khlebodarova TM; Bazhan SI; Gainova IA; Chereshnev VA; Bocharov GA
    BMC Genomics; 2014; 15 Suppl 12(Suppl 12):S1. PubMed ID: 25564443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing intra-lab precision and inter-lab repeatability of outgrowth assays of HIV-1 latent reservoir size.
    Rosenbloom DIS; Bacchetti P; Stone M; Deng X; Bosch RJ; Richman DD; Siliciano JD; Mellors JW; Deeks SG; Ptak RG; Hoh R; Keating SM; Dimapasoc M; Massanella M; Lai J; Sobolewski MD; Kulpa DA; Busch MP;
    PLoS Comput Biol; 2019 Apr; 15(4):e1006849. PubMed ID: 30978183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef.
    Fischer M; Joos B; Hirschel B; Bleiber G; Weber R; Günthard HF;
    J Infect Dis; 2004 Dec; 190(11):1979-88. PubMed ID: 15529263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.
    Metcalf Pate KA; Blankson JN
    Retrovirology; 2017 Nov; 14(1):52. PubMed ID: 29157283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 Reservoirs During Suppressive Therapy.
    Barton K; Winckelmann A; Palmer S
    Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scientific rationale for antiretroviral therapy in 2005: viral reservoirs and resistance evolution.
    Siliciano RF
    Top HIV Med; 2005; 13(3):96-100. PubMed ID: 16170226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
    Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
    AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Optimized Tat/Rev Induced Limiting Dilution Assay for the Characterization of HIV-1 Latent Reservoirs.
    Mishra S; Gohil Y; Mehta K; D'silva A; Amanullah A; Selvam D; Pargain N; Nala N; Sanjeeva GN; Ranga U
    Bio Protoc; 2022 Apr; 12(8):e4391. PubMed ID: 35800103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring the Inducible, Replication-Competent HIV Reservoir Using an Ultra-Sensitive p24 Readout, the Digital ELISA Viral Outgrowth Assay.
    Stuelke EL; James KS; Kirchherr JL; Allard B; Baker C; Kuruc JD; Gay CL; Margolis DM; Archin NM
    Front Immunol; 2020; 11():1971. PubMed ID: 32849659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4
    Sanyal A; Mailliard RB; Rinaldo CR; Ratner D; Ding M; Chen Y; Zerbato JM; Giacobbi NS; Venkatachari NJ; Patterson BK; Chargin A; Sluis-Cremer N; Gupta P
    Nat Med; 2017 Jul; 23(7):885-889. PubMed ID: 28553933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads.
    Metcalf Pate KA; Pohlmeyer CW; Walker-Sperling VE; Foote JB; Najarro KM; Cryer CG; Salgado M; Gama L; Engle EL; Shirk EN; Queen SE; Chioma S; Vermillion MS; Bullock B; Li M; Lyons CE; Adams RJ; Zink MC; Clements JE; Mankowski JL; Blankson JN
    J Infect Dis; 2015 Nov; 212(9):1387-96. PubMed ID: 25883388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.